Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntingtons disease patient cells

Molecular Brain

Volumn 5, Issue 1, 2012, Pages

  Juopperi, Tarja A ^a   Kim, Woon Ryoung ^a   Chiang, Cheng Hsuan ^a   Yu, Huimei ^a   Margolis, Russell L ^a   Ross, Christopher A ^a   Ming, Guo Li ^a   Song, Hongjun ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Astrocytes; Disease modeling; Huntingtons disease; Induced pluripotent stem cells; Neural differentiation

Indexed keywords

HUNTINGTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ASSAY; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINE; CELL SURVIVAL; CELL VACUOLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE; MALE; MOUSE; MUTATION; NERVE CELL; NEUROLOGIC DISEASE; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TRINUCLEOTIDE REPEAT;

ADULT; ANIMALS; ASTROCYTES; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; CHLOROQUINE; FEMALE; HUMANS; HUNTINGTON DISEASE; INDUCED PLURIPOTENT STEM CELLS; MALE; MICE; NEURAL STEM CELLS; NEURONS; STEM CELL TRANSPLANTATION; VACUOLES;

ANIMALIA;

EID: 84861203696     PISSN: None     EISSN: 17566606     Source Type: Journal    
DOI: 10.1186/1756-6606-5-17     Document Type: Article

References (66)

1. Huntingtons disease: seeing the pathogenic process through a genetic lens. Gusella JF, MacDonald ME, Trends Biochem Sci 2006 31 9 533 540 10.1016/j.tibs.2006.06.009 16829072
2. Huntingtons disease: from molecular pathogenesis to clinical treatment. Ross CA, Tabrizi SJ, Lancet Neurol 2011 10 1 83 98 10.1016/S1474-4422(10)70245-3 21163446
3. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntingtons disease chromosomes. Cell 1993 72 6 971 983 10.1016/0092-8674(93)90585-E 8458085
4. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N, Science 1997 277 5334 1990 1993 10.1126/science.277. 5334.1990 9302293
5. Huntingtons disease: from pathology and genetics to potential therapies. Imarisio S, Carmichael J, Korolchuk V, Chen CW, Saiki S, Rose C, Krishna G, Davies JE, Ttofi E, Underwood BR, et al. Biochem J 2008 412 2 191 209 10.1042/BJ20071619 18466116
6. Widespread expression of Huntingtons disease gene (IT15) protein product. Sharp AH, Loev SJ, Schilling G, Li SH, Li XJ, Bao J, Wagster MV, Kotzuk JA, Steiner JP, Lo A, et al. Neuron 1995 14 5 1065 1074 10.1016/0896-6273(95)90345-3 7748554
7. Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity. Li H, Li SH, Johnston H, Shelbourne PF, Li XJ, Nat Genet 2000 25 4 385 389 10.1038/78054 10932179
8. Huntingtin protein colocalizes with lesions of neurodegenerative diseases: an investigation in Huntingtons, Alzheimers, and Picks diseases. Singhrao SK, Thomas P, Wood JD, MacMillan JC, Neal JW, Harper PS, Jones AL, Exp Neurol 1998 150 2 213 222 10.1006/exnr.1998.6778 9527890
9. Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. Shin JY, Fang ZH, Yu ZX, Wang CE, Li SH, Li XJ, J Cell Biol 2005 171 6 1001 1012 10.1083/jcb.200508072 16365166
10. Huntington disease models and human neuropathology: similarities and differences. Vonsattel JP, Acta Neuropathol 2008 115 1 55 69 17978822
11. Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntingtons disease. Graveland GA, Williams RS, DiFiglia M, Science 1985 227 4688 770 773 10.1126/science.3155875 3155875
12. Neuronal loss in the hippocampus in Huntingtons disease: a comparison with HIV infection. Spargo E, Everall IP, Lantos PL, J Neurol Neurosurg Psychiatry 1993 56 5 487 491 10.1136/jnnp.56.5.487 8505640
13. Diagnosis of huntington disease. Margolis RL, Ross CA, Clin Chem 2003 49 10 1726 1732 10.1373/49.10.1726 14500613
14. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Lee JM RE, Lee JH, Gillis T, Mysore JS, Hayden MR, Warby SC, Morrison PNM, Ross CA, Margolis RL, Squitieri F, Orobello S, Di Donato S, Gomez-Tortosa EAC, Suchowersky O, Trent RJ, McCusker E, Novelletto A, Frontali MJR, Ashizawa T, Frank S, Saint-Hilaire MH, Hersch SM, Rosas HD, Lucente DHM, Zanko A, Abramson RK, Marder K, Sequeiros J, Paulsen JS, on behalf of the PREDICT-HD study of the Huntington Study Group (HSG), Huntingtons LGobotRsotE, Disease Network MRobotH-MSG, Macdonald ME, HSG. GJobotCsot, Neurology 2012 78 1 690 695 10.1212/WNL.0b013e318249f683 22323755
15. Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease. Ranen NG, Stine OC, Abbott MH, Sherr M, Codori AM, Franz ML, Chao NI, Chung AS, Pleasant N, Callahan C, et al. Am J Hum Genet 1995 57 3 593 602 7668287
16. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntingtons disease. Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilmann J, Adam S, Starr E, Squitieri F, Lin B, Kalchman MA, et al. Nat Genet 1993 4 4 398 403 10.1038/ng0893-398 8401589
17. Human embryonic stem cell models of Huntington disease. Niclis JC, Trounson AO, Dottori M, Ellisdon AM, Bottomley SP, Verlinsky Y, Cram DS, Reprod Biomed Online 2009 19 1 106 113 10.1016/S1472-6483(10)60053-3 19573298
18. Derivation of Huntingtons disease-affected human embryonic stem cell lines. Bradley CK, Scott HA, Chami O, Peura TT, Dumevska B, Schmidt U, Stojanov T, Stem Cells Dev 2011 20 3 495 502 10.1089/scd.2010.0120 20649476
19. Rodent genetic models of Huntington disease. Heng MY, Detloff PJ, Albin RL, Neurobiol Dis 2008 32 1 1 9 10.1016/j.nbd.2008.06.005 18638556
20. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L, Bates GP, Cell 1997 90 3 537 548 10.1016/S0092-8674(00)80513-9 9267033
21. Convergent pathogenic pathways in Alzheimers and Huntingtons diseases: shared targets for drug development. Ehrnhoefer DE, Wong BK, Hayden MR, Nat Rev Drug Discov 2011 10 11 853 867 10.1038/nrd3556 22015920
22. Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms. Bradford J, Shin JY, Roberts M, Wang CE, Li XJ, Li S, Proc Natl Acad Sci U S A 2009 106 52 22480 22485 10.1073/pnas. 0911503106 20018729
23. Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice. Bradford J, Shin JY, Roberts M, Wang CE, Sheng G, Li S, Li XJ, J Biol Chem 2010 285 14 10653 10661 10.1074/jbc.M109.083287 20145253
24. In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntingtons disease subjects. Faideau M, Kim J, Cormier K, Gilmore R, Welch M, Auregan G, Dufour N, Guillermier M, Brouillet E, Hantraye P, et al. Hum Mol Genet 2010 19 15 3053 3067 10.1093/hmg/ddq212 20494921
25. Cholesterol defect is marked across multiple rodent models of Huntingtons disease and is manifest in astrocytes. Valenza M, Leoni V, Karasinska JM, Petricca L, Fan J, Carroll J, Pouladi MA, Fossale E, Nguyen HP, Riess O, et al. J Neurosci 2010 30 32 10844 10850 10.1523/JNEUROSCI.0917-10.2010 20702713
26. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Takahashi K, Yamanaka S, Cell 2006 126 4 663 676 10.1016/j.cell.2006.07.024 16904174
27. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S, Cell 2007 131 5 861 872 10.1016/j.cell.2007.11.019 18035408
28. Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Staerk J, Dawlaty MM, Gao Q, Maetzel D, Hanna J, Sommer CA, Mostoslavsky G, Jaenisch R, Cell Stem Cell 2010 7 1 20 24 10.1016/j.stem.2010.06.002 20621045
29. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Seki T, Yuasa S, Oda M, Egashira T, Yae K, Kusumoto D, Nakata H, Tohyama S, Hashimoto H, Kodaira M, et al. Cell Stem Cell 2010 7 1 11 14 10.1016/j.stem.2010.06.003 20621043
30. Embryonic stem cell lines derived from human blastocysts. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM, Science 1998 282 5391 1145 1147 9804556
31. Modeling neurological diseases using patient-derived induced pluripotent stem cells. Juopperi TA, Song H, Ming GL, Future Neurol 2011 6 3 363 373 10.2217/fnl.11.14 21731471
32. Probing sporadic and familial Alzheimers disease using induced pluripotent stem cells. Israel MA, Yuan SH, Bardy C, Reyna SM, Mu Y, Herrera C, Hefferan MP, Van Gorp S, Nazor KL, Boscolo FS, et al. Nature 2012 482 7384 216 220 22278060
33. Induced pluripotent stem cells: a new revolution for clinical neurology? Mattis VB, Svendsen CN, Lancet Neurol 2011 10 4 383 394 10.1016/S1474-4422(11) 70022-9 21435601
34. Modeling familial Alzheimers disease with induced pluripotent stem cells. Yagi T, Ito D, Okada Y, Akamatsu W, Nihei Y, Yoshizaki T, Yamanaka S, Okano H, Suzuki N, Hum Mol Genet 2011 20 23 4530 4539 10.1093/hmg/ddr394 21900357
35. Cellular reprogramming: recent advances in modeling neurological diseases. Ming GL, Brustle O, Muotri A, Studer L, Wernig M, Christian KM, J Neurosci 2011 31 45 16070 16075 10.1523/JNEUROSCI.4218-11.2011 22072658
36. Integrative genomic and functional analyses reveal neuronal subtype differentiation bias in human embryonic stem cell lines. Wu H, Xu J, Pang ZP, Ge W, Kim KJ, Blanchi B, Chen C, Sudhof TC, Sun YE, Proc Natl Acad Sci U S A 2007 104 34 13821 13826 10.1073/pnas.0706199104 17693548
37. Derivation and characterization of neuronal precursors and dopaminergic neurons from human embryonic stem cells in vitro. Carpenter M, Rao MS, Freed W, Zeng X, Methods Mol Biol 2006 331 153 167 16881516
38. Assessment of stromal-derived inducing activity in the generation of dopaminergic neurons from human embryonic stem cells. Vazin T, Chen J, Lee CT, Amable R, Freed WJ, Stem Cells 2008 26 6 1517 1525 10.1634/stemcells.2008-0039 18388303
39. Neural stem cells from adult hippocampus develop essential properties of functional CNS neurons. Song HJ, Stevens CF, Gage FH, Nat Neurosci 2002 5 5 438 445 11953752
40. Adult neurogenesis in the mammalian brain: significant answers and significant questions. Ming GL, Song H, Neuron 2011 70 4 687 702 10.1016/j.neuron.2011.05.001 21609825
41. LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. Kabeya Y, Mizushima N, Yamamoto A, Oshitani-Okamoto S, Ohsumi Y, Yoshimori T, J Cell Sci 2004 117 Pt 13 2805 2812 15169837
42. Guidelines and techniques for the generation of induced pluripotent stem cells. Maherali N, Hochedlinger K, Cell Stem Cell 2008 3 6 595 605 10.1016/j.stem.2008.11.008 19041776
43. Induced pluripotent stem cells from patiwnts with Huntingtons Disease show CAG repeat expansion associated phenotypes. Cell Stem Cell 2012 In press
44. Characterization of human Huntingtons disease cell model from induced pluripotent stem cells. Zhang N, An MC, Montoro D, Ellerby LM, PLoS Curr 2010 2 RN1193 21037797
45. Parkinsons disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, Hargus G, Blak A, Cooper O, Mitalipova M, et al. Cell 2009 136 5 964 977 10.1016/j.cell.2009.02.013 19269371
46. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, Croft GF, Saphier G, Leibel R, Goland R, et al. Science 2008 321 5893 1218 1221 10.1126/science.1158799 18669821
47. Astroglia induce neurogenesis from adult neural stem cells. Song H, Stevens CF, Gage FH, Nature 2002 417 6884 39 44 10.1038/417039a 11986659
48. Do astrocytes really exocytose neurotransmitters? Hamilton NB, Attwell D, Nat Rev Neurosci 2010 11 4 227 238 10.1038/nrn2803 20300101
49. Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Di Giorgio FP, Boulting GL, Bobrowicz S, Eggan KC, Cell Stem Cell 2008 3 6 637 648 10.1016/j.stem.2008.09.017 19041780
50. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Di Giorgio FP, Carrasco MA, Siao MC, Maniatis T, Eggan K, Nat Neurosci 2007 10 5 608 614 10.1038/nn1885 17435754
51. Glia: initiators and progressors of pathology in Parkinsons disease. Halliday GM, Stevens CH, Mov Disord 2011 26 1 6 17 10.1002/mds.23455 21322014
52. Astrocytes in Alzheimers disease: emerging roles in calcium dysregulation and synaptic plasticity. Vincent AJ, Gasperini R, Foa L, Small DH, J Alzheimers Dis 2010 22 3 699 714 20847426
53. Expression of mutant N-terminal huntingtin fragment (htt552-100Q) in astrocytes suppresses the secretion of BDNF. Wang L, Lin F, Wang J, Wu J, Han R, Zhu L, Difiglia M, Qin Z, Brain Res 2012 1449 69 82 22410294
54. Autophagosome-like vacuole formation in Huntingtons disease lymphoblasts. Nagata E, Sawa A, Ross CA, Snyder SH, Neuroreport 2004 15 8 1325 1328 10.1097/01.wnr.0000127073.66692.8f 15167559
55. Cargo recognition failure is responsible for inefficient autophagy in Huntingtons disease. Martinez-Vicente M, Talloczy Z, Wong E, Tang G, Koga H, Kaushik S, de Vries R, Arias E, Harris S, Sulzer D, et al. Nat Neurosci 2010 13 5 567 576 10.1038/nn.2528 20383138
56. Induced pluripotent stem cells from a spinal muscular atrophy patient. Ebert AD, Yu J, Rose FF, Mattis VB, Lorson CL, Thomson JA, Svendsen CN, Nature 2009 457 7227 277 280 10.1038/nature07677 19098894
57. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Marchetto MC, Carromeu C, Acab A, Yu D, Yeo GW, Mu Y, Chen G, Gage FH, Muotri AR, Cell 2010 143 4 527 539 10.1016/j.cell.2010. 10.016 21074045
58. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Lee G, Papapetrou EP, Kim H, Chambers SM, Tomishima MJ, Fasano CA, Ganat YM, Menon J, Shimizu F, Viale A, et al. Nature 2009 461 7262 402 406 10.1038/nature08320 19693009
59. Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation. Chiang CH, Su Y, Wen Z, Yoritomo N, Ross CA, Margolis RL, Song H, Ming GL, Mol Psychiatry 2011 16 4 358 360 10.1038/mp.2011.13 21339753
60. Generation and characterization of human induced pluripotent stem cells. Ohnuki M, Takahashi K, Yamanaka S, Curr Protoc Stem Cell Biol 2009 Chapter 4 nit 4A 2 19536759
61. G9a and Jhdm2a regulate embryonic stem cell fusion-induced reprogramming of adult neural stem cells. Ma DK, Chiang CH, Ponnusamy K, Ming GL, Song H, Stem Cells 2008 26 8 2131 2141 10.1634/stemcells.2008-0388 18535151
62. Teratoma formation by human embryonic stem cells is site dependent and enhanced by the presence of matrigel. Prokhorova TA, Harkness LM, Frandsen U, Ditzel N, Schroder HD, Burns JS, Kassem M, Stem Cells Dev 2009 18 1 47 54 10.1089/scd.2007.0266 18393673
63. GABA regulates synaptic integration of newly generated neurons in the adult brain. Ge S, Goh EL, Sailor KA, Kitabatake Y, Ming GL, Song H, Nature 2006 439 7076 589 593 10.1038/nature04404 16341203
64. Disrupted-In-Schizophrenia 1 regulates integration of newly generated neurons in the adult brain. Duan X, Chang JH, Ge S, Faulkner RL, Kim JY, Kitabatake Y, Liu XB, Yang CH, Jordan JD, Ma DK, et al. Cell 2007 130 6 1146 1158 10.1016/j.cell.2007.07.010 17825401
65. In vivo clonal analysis reveals self-renewing and multipotent adult neural stem cell characteristics. Bonaguidi MA, Wheeler MA, Shapiro JS, Stadel RP, Sun GJ, Ming GL, Song H, Cell 2011 145 7 1142 1155 10.1016/j.cell.2011.05. 024 21664664
66. Interplay between DISC1 and GABA signaling regulates neurogenesis in mice and risk for schizophrenia. Kim JY, Liu CY, Zhang F, Duan X, Wen Z, Song J, Feighery E, Lu B, Rujescu D, Clair D, et al. Cell 2012 148 5 1051 1064 10.1016/j.cell.2011.12.037 22385968